STC2 is upregulated in hepatocellular carcinoma and promotes cell proliferation and migration in vitro |
Wang, Haixiao
(Department of Hepatobiliary Surgery, Wuxi People's Hospital of Nanjing Medical University)
Wu, Kuangjie (Department of Hepatobiliary Surgery, Wuxi People's Hospital of Nanjing Medical University) Sun, Yuan (Department of Pharmacy, Huaian No. 1 People's Hospital Affiliated to Nanjing Medical University) Li, Yandong (Chinese National Human Genome Center, Rui-Jin Hospital, Shanghai Jiaotong University School of Medicine) Wu, Mingyu (Department of Hepatobiliary Surgery, Wuxi People's Hospital of Nanjing Medical University) Qiao, Qian (Department of Hepatobiliary Surgery, Wuxi People's Hospital of Nanjing Medical University) Wei, Yuanjiang (Department of Hepatobiliary Surgery, Wuxi People's Hospital of Nanjing Medical University) Han, Ze-Guang (Chinese National Human Genome Center, Rui-Jin Hospital, Shanghai Jiaotong University School of Medicine) Cai, Bing (Department of Hepatobiliary Surgery, Wuxi People's Hospital of Nanjing Medical University) |
1 | Jemal, A., Bray, F., Center, M. M., Ferlay, J., Ward, E. and Forman, D. (2011) Global cancer statistics. CA Cancer J. Clin. 61, 69-90. DOI |
2 | Sherman, M. (2005) Hepatocellular carcinoma: epidemiology, risk factors, and screening. Semin. Liver Dis. 25, 143-154. DOI ScienceOn |
3 | Hwang, S., Moon, D. B. and Lee, S. G. (2010) Liver transplantation and conventional surgery for advanced hepatocellular carcinoma. Transpl. Int. 23, 723-727. DOI ScienceOn |
4 | Villanueva, A. and Llovet, J. M. (2011) Targeted therapies for hepatocellular carcinoma. Gastroenterology. 140, 1410-1426. DOI ScienceOn |
5 | Livraghi, T., Makisalo, H. and Line, P. D. (2011) Treatment options in hepatocellular carcinoma today. Scand. J. Surg. 100, 22-29. DOI |
6 | Zender, L., Spector, M. S., Xue, W., Flemming, P., Cordon-Cardo, C., Silke, J., Fan, S. T., Luk, J. M., Wigler, M., Hannon, G. J., Mu, D., Lucito, R., Powers, S. and Lowe, S. W. (2006) Identification and validation of oncogenes in liver cancer using an integrative oncogenomic approach. Cell 125, 1253-1267. DOI ScienceOn |
7 | Levine, A. J. and Puzio-Kuter, A. M. (2010) The control of the metabolic switch in cancers by oncogenes and tumor suppressor genes. Science. 330, 1340-1344. DOI ScienceOn |
8 | Flik, G., Labedz, T., Neelissen, J. A., Hanssen, R. G., Wendelaar Bonga, S. E. and Pang, P. K. (1990) Rainbow trout corpuscles of Stannius: stanniocalcin synthesis in vitro. Am. J. Physiol. 258, R1157-1164. |
9 | Sterba, T., Wagner, G. F., Schroedter, I. C. and Friesen, H. G. (1993) In situ detection and distribution of stanniocalcin mRNA in the corpuscles of Stannius of sockeye salmon, Oncorhynchus nerka. Mol. Cell Endocrinol. 90, 179-185. DOI ScienceOn |
10 | Honda, S., Kashiwagi, M., Ookata, K., Tojo, A. and Hirose, S. (1999) Regulation by 1alpha,25-dihydroxyvitamin D(3) of expression of stanniocalcin messages in the rat kidney and ovary. FEBS Lett. 459, 119-122. DOI ScienceOn |
11 | Wagner, G. F., Jaworski, E. M. and Haddad, M. (1998) Stanniocalcin in the seawater salmon: structure, function, and regulation. Am. J. Physiol. 274, R1177-1185. |
12 | Moore, E. E., Kuestner, R. E., Conklin, D. C., Whitmore, T. E., Downey, W., Buddle, M. M., Adams, R. L., Bell, L. A., Thompson, D. L., Wolf, A., Chen, L., Stamm, M. R., Grant, F. J., Lok, S., Ren, H. and De Jongh, K. S. (1999) Stanniocalcin 2: characterization of the protein and its localization to human pancreatic alpha cells. Horm. Metab Res. 31, 406-414. DOI |
13 | Ishibashi, K., Miyamoto, K., Taketani, Y., Morita, K., Takeda, E., Sasaki, S. and Imai, M. (1998) Molecular cloning of a second human stanniocalcin homologue (STC2). Biochem. Biophys. Res. Commun. 250, 252-258. DOI ScienceOn |
14 | Nguyen, A., Chang, A. C. and Reddel, R. R. (2009) Stanniocalcin-1 acts in a negative feedback loop in the prosurvival ERK1/2 signaling pathway during oxidative stress. Oncogene. 28, 1982-1992. DOI ScienceOn |
15 | Lai, K. P., Law, A. Y., Yeung, H. Y., Lee, L. S., Wagner, G. F. and Wong, C. K. (2007) Induction of stanniocalcin-1 expression in apoptotic human nasopharyngeal cancer cells by p53. Biochem. Biophys. Res. Commun. 356, 968-975. DOI ScienceOn |
16 | Tamura, K., Furihata, M., Chung, S. Y., Uemura, M., Yoshioka, H., Iiyama, T., Ashida, S., Nasu, Y., Fujioka, T., Shuin, T., Nakamura, Y. and Nakagawa, H. (2009) Stanniocalcin 2 overexpression in castration-resistant prostate cancer and aggressive prostate cancer. Cancer Sci. 100, 914-919. DOI ScienceOn |
17 | Law, A. Y. and Wong, C. K. (2010) Stanniocalcin-2 promotes epithelial-mesenchymal transition and invasiveness in hypoxic human ovarian cancer cells. Exp. Cell Res. 316, 3425-3434. DOI ScienceOn |
18 | Volland, S., Kugler, W., Schweigerer, L., Wilting, J. and Becker, J. (2009) Stanniocalcin 2 promotes invasion and is associated with metastatic stages in neuroblastoma. Int. J. Cancer. 125, 2049-2057. DOI ScienceOn |
19 | Ito D, Walker, J. R., Thompson, C. S., Moroz, I., Lin, W., Veselits, M. L., Hakim, A. M., Fienberg, A. A., Thinakaran, G. (2004) Characterization of stanniocalcin 2, a novel target of the mammalian unfolded protein response with cytoprotective properties. Mol. Cell Biol. 24, 9456-9469. DOI ScienceOn |
20 | Fazio, E. N., Dimattia, G. E., Chadi, S. A., Kernohan, K. D., Pin CL. (2011) Stanniocalcin 2 alters PERK signalling and reduces cellular injury during cerulein induced pancreatitis in mice. BMC Cell Biol. 12, 17. DOI ScienceOn |
21 | Tarn, W. Y. and Lai, M. C. (2011) Translational control of cyclins. Cell Div. 6,5. DOI ScienceOn |
22 | Meyer, H. A., Tolle, A., Jung, M., Fritzsche, F. R., Haendler, B., Kristiansen, I., Gaspert, A., Johannsen, M., Jung, K. and Kristiansen, G. (2009) Identification of stanniocalcin 2 as prognostic marker in renal cell carcinoma. Eur Urol. 55, 669-678. DOI ScienceOn |
23 | Yokobori, T., Mimori, K., Ishii, H., Iwatsuki, M., Tanaka, F., Kamohara, Y., Ieta, K., Kita, Y., Doki, Y., Kuwano, H. and Mori, M. (2010) Clinical significance of stanniocalcin 2 as a prognostic marker in gastric cancer. Ann. Surg. Oncol. 17, 2601-2607. DOI |
24 | Yamamura, J., Miyoshi, Y., Tamaki, Y., Taguchi, T., Iwao, K., Monden, M., Kato, K. and Noguchi, S. (2004) mRNA expression level of estrogen-inducible gene, alpha 1-antichymotrypsin, is a predictor of early tumor recurrence in patients with invasive breast cancers. Cancer Sci. 95, 887-892. DOI ScienceOn |
25 | Schmitz, K. J., Wohlschlaeger, J., Lang, H., Sotiropoulos, G. C., Malago, M., Steveling, K., Reis, H., Cicinnati, V. R., Schmid, K. W. and Baba, H. A. (2008) Activation of the ERK and AKT signalling pathway predicts poor prognosis in hepatocellular carcinoma and ERK activation in cancer tissue is associated with hepatitis C virus infection. J Hepatol. 48, 83-90. DOI ScienceOn |
26 | Too, H. P. (2003) Real time PCR quantification of GFRalpha-2 alternatively spliced isoforms in murine brain and peripheral tissues. Brain Res. Mol. Brain Res. 114, 146-153. DOI ScienceOn |
27 | Qin, L. X. and Tang, Z. Y. (2002) The prognostic significance of clinical and pathological features in hepatocellular carcinoma. World J. Gastroenterol. 8, 193-199. DOI |